Castleview Partners’s Viatris VTRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-24
Closed -$255 920
2024
Q2
$255 Hold
24
﹤0.01% 874
2024
Q1
$287 Sell
24
-12
-33% -$145 ﹤0.01% 855
2023
Q4
$390 Hold
36
﹤0.01% 815
2023
Q3
$354 Sell
36
-64
-64% -$666 ﹤0.01% 649
2023
Q2
$1K Sell
100
-258
-72% -$2.46K ﹤0.01% 633
2023
Q1
$3.44K Hold
358
﹤0.01% 530
2022
Q4
$3.98K Buy
358
+27
+8% +$282 ﹤0.01% 459
2022
Q3
$3K Sell
331
-369
-53% -$3.63K ﹤0.01% 511
2022
Q2
$20.9K Buy
700
+245
+54% +$2.69K 0.02% 383
2022
Q1
$4K Buy
+455
New +$6K ﹤0.01% 598
2021
Q2
$36K Buy
+2,541
New +$36.8K 0.02% 472

Other funds holding VTRS

Castleview Partners's VTRS Position: Q3 2024 in Review

Castleview Partners sold out of Viatris (VTRS) in Q3 2024, closing a stake of 24 shares — an estimated $255 sold.

Castleview Partners first reported a position in VTRS in Q2 2021 and held it in 11 quarters. The position peaked at $36K in Q2 2021. 1,002 funds tracked by Wall St. Rank hold VTRS as of Q3 2024.

  • Castleview Partners reported no remaining Viatris position as of Q3 2024 after selling out during the quarter.
  • Castleview Partners sold 24 Viatris shares in Q3 2024, an estimated $255.
  • Castleview Partners first reported a position in Viatris in Q2 2021 and held it in 11 quarters.
  • Castleview Partners's Viatris position peaked at $36K in Q2 2021.
  • 1,002 funds tracked by Wall St. Rank held Viatris as of Q3 2024.

Based on Castleview Partners's 13F filing for Q3 2024, filed 9 Oct 2024.